Drug Detail:Crestor (Rosuvastatin [ roe-soo-va-sta-tin ])
Generic Name: ROSUVASTATIN CALCIUM 5mg
Dosage Form: tablet, film coated
Drug Class: Statins
General Dosage and Administration Information
- •
- Administer CRESTOR orally as a single dose at any time of day, with or without food. The tablet should be swallowed whole.
- •
- Assess LDL-C when clinically appropriate, as early as 4 weeks after initiating CRESTOR, and adjust the dosage if necessary.
- •
- If a dose is missed, advise patients not take an extra dose. Resume treatment with the next dose.
Recommended Dosage in Adult Patients
- •
- The dosage range for CRESTOR is 5 to 40 mg orally once daily.
- •
- The recommended dose of CRESTOR depends on a patient’s indication for usage, LDL-C, and individual risk for cardiovascular events.
Recommended Dosage in Pediatric Patients
Dosage in Pediatric Patients 8 Years of Age and Older with HeFH
The recommended dosage range is 5 mg to 10 mg orally once daily in patients aged 8 years to less than 10 years and 5 mg to 20 mg orally once daily in patients aged 10 years and older.
Dosage in Pediatric Patients 7 Years of Age and Older with HoFH
The recommended dosage is 20 mg orally once daily.
Dosing in Asian Patients
Initiate CRESTOR at 5 mg once daily due to increased rosuvastatin plasma concentrations. Consider the risks and benefits of CRESTOR when treating Asian patients not adequately controlled at doses up to 20 mg once daily [see Warnings and Precautions (5.1), Use in Specific Populations (8.8), and Clinical Pharmacology (12.3)].
Recommended Dosage in Patients with Renal Impairment
In patients with severe renal impairment (CLcr less than 30 mL/min/1.73 m2) not on hemodialysis, the recommended starting dosage is 5 mg once daily and should not exceed 10 mg once daily [see Warnings and Precautions (5.1) and Use in Specific Populations (8.6)].
There are no dosage adjustment recommendations for patients with mild and moderate renal impairment.
Dosage and Administration Modifications Due to Drug Interactions
CRESTOR Dosage Modifications Due to Drug Interactions
Table 1 displays dosage modifications for CRESTOR due to drug interactions [see Warnings and Precautions (5.1) and Drug Interactions (7.1)].
Concomitantly Used Drug |
CRESTOR Dosage Modifications |
Cyclosporine |
Do not exceed 5 mg once daily. |
Teriflunomide |
Do not exceed 10 mg once daily. |
Capmatinib |
Do not exceed 10 mg once daily. |
Fostamatinib |
Do not exceed 20 mg once daily. |
Febuxostat |
Do not exceed 20 mg once daily. |
Gemfibrozil |
Avoid concomitant use. If used concomitantly, initiate at 5 mg once daily and do not exceed 10 mg once daily. |
Tafamidis |
Avoid concomitant use. If used concomitantly, initiate at 5 mg once daily and do not exceed 10 mg once daily. |
Antiviral Medications |
|
|
Concomitant use not recommended. |
|
Initiate at 5 mg once daily. Do not exceed 10 mg once daily. |
Darolutamide |
Do not exceed 5 mg once daily. |
Regorafenib |
Do not exceed 10 mg once daily. |
CRESTOR Administration Modifications Due to Drug Interactions
When taking CRESTOR with an aluminum and magnesium hydroxide combination antacid, administer CRESTOR at least 2 hours before the antacid [see Drug Interactions (7.2)].